Clipping of news on Brazilian Culture, Law and Citizenship
08/04/2015
This article was translated by an automatic translation system, and was therefore not reviewed by people.
transparent image
Anvisa suspended the distribution, sale and use of the lot No. 335601 of medicine Triatec 2.5 mg tablets and lots 2S6828, 327388 and 341288 of the drug Triatec 5 mg tablets manufactured by Sanofi-Aventis Pharmaceuticals Ltda.
The Drug Post-registration audit performed in the company confirmed the manufacturing and distribution of lots with an expiration date changed from 24 to 36 months in violation of the approved in the registry.
It was determined the collection of existing stock on the market of consignments of medicines.
The measure is in Resolution No. 1052, published on Monday (7/4) in the Official Gazette.
Check out the resolutions in the Official Gazette
Source: ANVISA
To access the ANVISA site, click here.
Our news are taken in full of our partner sites. For this reason, we can not change their content even in cases of typos. transparent image
This article was translated by an automatic translation system, and was therefore not reviewed by people.